Prometheus launches Crohn’s Prognostic test
Prometheus launches Crohn’s Prognostic test
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn’s Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
Read more on News-Medical-Net
Categories: Breast Cancer Doctors Tags: Crohn's, Launches, Prognostic, Prometheus, test
Clarient receives patent for Mammostrat breast cancer prognostic test
Clarient receives patent for Mammostrat breast cancer prognostic test
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer …
Read more on News-Medical-Net
Categories: Breast Cancer In Men Tags: breast, cancer, Clarient, Mammostrat, Patent, Prognostic, receives, test
Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual …
Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual …
Huntington Beach, California and Amsterdam, June 4, 2010 (ots/PRNewswire) – Agendia, a world leader in molecular cancer diagnostics, today announced that …
Read more on FinanzNachrichten
Categories: Breast Cancer Doctors Tags: 2010, Agendia, annual, Array, ASCO, breast, Broad, cancers, Colorectal, Predictive, presents, Prognostic, Studies